Trial Outcomes & Findings for TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh (NCT NCT01481376)

NCT ID: NCT01481376

Last Updated: 2016-01-07

Results Overview

Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.

Recruitment status

COMPLETED

Target enrollment

200 participants

Primary outcome timeframe

At least 12 months post-surgery

Results posted on

2016-01-07

Participant Flow

Participant milestones

Participant milestones
Measure
Parietex Progrip
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Overall Study
STARTED
200
Overall Study
COMPLETED
169
Overall Study
NOT COMPLETED
31

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Age, Continuous
54.7 years
n=5 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
Sex: Female, Male
Male
156 Participants
n=5 Participants

PRIMARY outcome

Timeframe: At least 12 months post-surgery

Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.

Outcome measures

Outcome measures
Measure
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery.
3 participants

SECONDARY outcome

Timeframe: 12 month post-operatively

Outcome measures

Outcome measures
Measure
Parietex Progrip
n=168 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Incidence of Groin Pain (Pain Score 0-10)
No/Low Pain (score 0-3)
160 participants
Incidence of Groin Pain (Pain Score 0-10)
Mild pain (Score 4-6)
6 participants
Incidence of Groin Pain (Pain Score 0-10)
Severe (score 7-10)
2 participants

SECONDARY outcome

Timeframe: The day of the discharge (an expected average of 1 day), 1month and at least 12 month post-operatively

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: up to 12 months

Outcome measures

Outcome measures
Measure
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Hematoma/Seroma
3 participants
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Emphysema in the inguinal regions (both sides)
1 participants
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Secondary hemorrhage through the trocar's site
2 participants
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Hematuria
1 participants
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Swelling above the genital organs
1 participants

SECONDARY outcome

Timeframe: at least 12 month post-operatively

Outcome measures

Outcome measures
Measure
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Patient Satisfaction
Very satisfied/Satisfied
162 participants
Patient Satisfaction
Neutral
2 participants
Patient Satisfaction
Unsatisfied/Very unsatisfied
5 participants

SECONDARY outcome

Timeframe: From skin incision to closure (The expected median operating time is 36 minutes for unilateral and 50 minutes for bilateral repair)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Duration of the hospital stay (expected average of 1 day)

Outcome measures

Outcome measures
Measure
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
Hospital Length of Stay
2.1 Days
Standard Deviation 0.8

Adverse Events

Parietex Progrip

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Docteur Dieter BIRK

Surgical Department of the Protestant Hospital

Phone: 06332 422120

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60